Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. The Medical City brings home five wins at Healthcare Asia Awards 2025 2. Gleneagles HK to advance health solutions through new partnerships 3. IHH Healthcare to fast-track shift to value-based care 4. China’s biopharma sector strikes $30b in oncology licensing deals 5. SingHealth, Philips to roll out smart ICUs to cut false alarmsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
It was recognised for its success in delivering world-class specialised services that rival the best healthcare institutions globally.
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare